103 related articles for article (PubMed ID: 30711952)
1. Antiangiogenic Human Monoclonal Antibody Ramucirumab Radiolabelling:
Janousek J; Barta P; Novy Z; Zilkova K; Trejtnar F
Anticancer Res; 2019 Feb; 39(2):735-744. PubMed ID: 30711952
[No Abstract] [Full Text] [Related]
2. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
3. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
4. Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent.
Mohammadgholi M; Sadeghzadeh N; Erfani M; Abediankenari S; Abedi SM; Emrarian I; Jafari N; Behzadi R
Anticancer Agents Med Chem; 2018; 18(2):277-285. PubMed ID: 28925879
[TBL] [Abstract][Full Text] [Related]
5. Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide.
Karczmarczyk U; Garnuszek P; Maurin M; Di Gialleonardo V; Galli F; Signore A; Mikołajczak R
Nucl Med Biol; 2010 Oct; 37(7):795-803. PubMed ID: 20870154
[TBL] [Abstract][Full Text] [Related]
6. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
7. Automated radiolabelling of monoclonal antibodies with the Modular Lab system.
Ellison D; Kaufman J; Mather SJ
Nucl Med Commun; 2010 Feb; 31(2):173-7. PubMed ID: 19952855
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging.
Novy Z; Janousek J; Barta P; Petrik M; Hajduch M; Trejtnar F
J Labelled Comp Radiopharm; 2021 Jun; 64(7):262-270. PubMed ID: 33818828
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m- Arg-Arg-Leu(g2), a modified peptide probe targeted to neovascularization in molecular tumor imaging.
Lu X; Zhao L; Xue T; Zhang H
J BUON; 2013; 18(4):1074-81. PubMed ID: 24344042
[TBL] [Abstract][Full Text] [Related]
10. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
[TBL] [Abstract][Full Text] [Related]
11. (99m)Tc-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agent.
Stopar TG; Mlinaric-Rascan I; Fettich J; Hojker S; Mather SJ
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):53-9. PubMed ID: 16172899
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.
De K; Banerjee I; Misra M
Amino Acids; 2015 Jun; 47(6):1135-53. PubMed ID: 25743164
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and preparation of technetium-99m-labeled D-D₃ monoclonal antibody against pro-gastrin-releasing peptide (₃₁₋₉₈) in mice.
Hao LJ; Hong ZH; Shi YZ; Liu ZL; Zhou XL
Chin Med J (Engl); 2013 Apr; 126(7):1333-6. PubMed ID: 23557567
[TBL] [Abstract][Full Text] [Related]
14. Determination of the radiochemical purity of (99m) Tc medronate injection by thin layer chromatography on iTLC-SG: effect of medronate concentration on the value measured.
Cunnane CM; O'Brien LM; Waight LA; Millar AM
J Labelled Comp Radiopharm; 2013 May; 56(5):301-4. PubMed ID: 24285375
[TBL] [Abstract][Full Text] [Related]
15. Imaging thrombosis with
Ouadi A; Bekaert V; Receveur N; Thomas L; Lanza F; Marchand P; Gachet C; Mangin PH; Brasse D; Laquerriere P
Nucl Med Biol; 2018 Jun; 61():21-27. PubMed ID: 29625391
[TBL] [Abstract][Full Text] [Related]
16. Clinical translation of a PSMA inhibitor for
Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
[TBL] [Abstract][Full Text] [Related]
17. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-epsilon-(hynic-Boc)-lysine, a technetium-binding amino acid: application to Tc-99m-labeled salmon calcitonin.
Greenland WE; Howland K; Hardy J; Fogelman I; Blower PJ
J Med Chem; 2003 Apr; 46(9):1751-7. PubMed ID: 12699393
[TBL] [Abstract][Full Text] [Related]
19.
Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
[TBL] [Abstract][Full Text] [Related]
20. Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.
Makris G; Tseligka ED; Pirmettis I; Papadopoulos MS; Vizirianakis IS; Papagiannopoulou D
Mol Pharm; 2016 Jul; 13(7):2301-17. PubMed ID: 27170456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
